{"hands_on_practices": [{"introduction": "The activation of immune cells via Fc receptors is critically dependent on receptor cross-linking, a process driven by the multivalent nature of antibody-antigen immune complexes. This first exercise moves from a qualitative understanding to a quantitative model of this principle. By deriving the minimal valency an immune complex must possess to achieve a specific number of receptor bonds, you will explore the fundamental biophysical link between a ligand's architecture and a cell's signaling threshold. [@problem_id:2847979]", "problem": "An Immunoglobulin G (IgG) immune complex of valency $v$ presents $v$ identical Fc sites to a cell surface bearing Fc gamma receptors (FcγR). Consider a quasi-steady, membrane-membrane contact patch of area $A_{c}$ where both FcγR and Fc sites are free to diffuse and are well mixed within the patch. Each Fc site binds at most one FcγR, and each FcγR binds at most one Fc site. Let the receptor surface density be $\\rho$ (number per unit area), and let the two-dimensional dissociation constant for the Fc–FcγR interaction be $K_{D}^{2D}$ (in the same surface-density units as $\\rho$). Activation of FcγR signaling requires an expected number $s$ of simultaneous Fc–FcγR bonds within the patch.\n\nStarting from the two-dimensional law of mass action at equilibrium and the fundamental definitions of free and bound densities in the contact patch, derive a closed-form analytical expression for the minimal valency $v^{\\ast}$ such that the expected number of concurrent Fc–FcγR bonds in the patch equals $s$ at equilibrium. Express your final result as a function of $s$, $\\rho$, $A_{c}$, and $K_{D}^{2D}$. Assume parameter values are such that a solution exists (that is, the required bond density does not exceed the receptor density), and ignore steric hindrance beyond mutual exclusivity of binding sites. The final answer should be a single analytic expression. No numerical evaluation is required, and no units should be included in the final answer.", "solution": "The problem as stated is scientifically grounded, well-posed, and objective. It presents a standard biophysical model of receptor-ligand interactions in two dimensions, which can be solved using the law of mass action. All required parameters are defined, and the objective is clear. Therefore, a solution will be derived.\n\nThe fundamental principle governing this system at equilibrium is the two-dimensional law of mass action. The reversible binding reaction between a free Fc gamma receptor ($R$) and a free Fc site ($L$) on the immune complex to form a bound complex ($C$) is given by:\n$$\nR + L \\rightleftharpoons C\n$$\nThe dissociation constant for this reaction in two dimensions, $K_{D}^{2D}$, is defined by the ratio of the surface densities of the free reactants to the surface density of the bound complexes at equilibrium:\n$$\nK_{D}^{2D} = \\frac{[R][L]}{[C]}\n$$\nwhere $[R]$, $[L]$, and $[C]$ represent the equilibrium surface densities of free receptors, free Fc sites, and Fc-FcγR complexes, respectively. The units of these densities and of $K_{D}^{2D}$ are number per unit area.\n\nLet us define the total densities of receptors and ligands within the contact patch of area $A_{c}$.\nThe total surface density of receptors is given as $\\rho$. By the law of conservation of mass, this total density is the sum of the free and bound receptor densities:\n$$\n\\rho = [R] + [C]\n$$\nThus, the free receptor density is:\n$$\n[R] = \\rho - [C]\n$$\nThe problem states there is a single immune complex of valency $v$. This means there are $v$ total Fc sites available for binding within the area $A_{c}$. The total surface density of these Fc sites, which we denote as $L_{total}$, is therefore:\n$$\nL_{total} = \\frac{v}{A_{c}}\n$$\nSimilarly, the total ligand density is the sum of free and bound ligand densities:\n$$\nL_{total} = [L] + [C]\n$$\nThus, the free ligand density is:\n$$\n[L] = L_{total} - [C] = \\frac{v}{A_{c}} - [C]\n$$\nThe problem requires that the expected number of simultaneous Fc–FcγR bonds in the patch equals $s$. The total number of bonds is the product of the bond density $[C]$ and the contact area $A_{c}$. Therefore, we have the condition:\n$$\n[C] A_{c} = s\n$$\nFrom this, we determine the required equilibrium density of bound complexes:\n$$\n[C] = \\frac{s}{A_{c}}\n$$\nNow, we substitute the expressions for $[R]$, $[L]$, and $[C]$ into the equilibrium equation for $K_{D}^{2D}$:\n$$\nK_{D}^{2D} = \\frac{\\left( \\rho - \\frac{s}{A_{c}} \\right) \\left( \\frac{v}{A_{c}} - \\frac{s}{A_{c}} \\right)}{\\frac{s}{A_{c}}}\n$$\nThe problem asks for the minimal valency, which we denote $v^{\\ast}$, that satisfies this condition. We proceed to solve for $v$.\nFirst, multiply both sides by the denominator $\\frac{s}{A_{c}}$:\n$$\nK_{D}^{2D} \\frac{s}{A_{c}} = \\left( \\rho - \\frac{s}{A_{c}} \\right) \\left( \\frac{v}{A_{c}} - \\frac{s}{A_{c}} \\right)\n$$\nWe can factor out $\\frac{1}{A_{c}}$ from the second term on the right-hand side:\n$$\nK_{D}^{2D} \\frac{s}{A_{c}} = \\left( \\rho - \\frac{s}{A_{c}} \\right) \\frac{1}{A_{c}} (v - s)\n$$\nMultiplying the entire equation by $A_{c}$ cancels the term on both sides:\n$$\nK_{D}^{2D} s = \\left( \\rho - \\frac{s}{A_{c}} \\right) (v - s)\n$$\nThe problem assumption that a solution exists implies that the required bond density does not exceed the total receptor density, i.e., $\\frac{s}{A_{c}}  \\rho$, which ensures that $\\rho - \\frac{s}{A_{c}} > 0$. We can therefore divide by this term to isolate $(v - s)$:\n$$\nv - s = \\frac{K_{D}^{2D} s}{\\rho - \\frac{s}{A_{c}}}\n$$\nFinally, we solve for $v$, which is our desired minimal valency $v^{\\ast}$:\n$$\nv^{\\ast} = s + \\frac{K_{D}^{2D} s}{\\rho - \\frac{s}{A_{c}}}\n$$\nTo present this as a single fraction, we first simplify the denominator of the second term:\n$$\n\\rho - \\frac{s}{A_{c}} = \\frac{\\rho A_{c} - s}{A_{c}}\n$$\nSubstituting this back into the expression for $v^{\\ast}$:\n$$\nv^{\\ast} = s + \\frac{K_{D}^{2D} s}{\\frac{\\rho A_{c} - s}{A_{c}}} = s + \\frac{K_{D}^{2D} s A_{c}}{\\rho A_{c} - s}\n$$\nNow, we find a common denominator to combine the terms:\n$$\nv^{\\ast} = \\frac{s(\\rho A_{c} - s) + K_{D}^{2D} s A_{c}}{\\rho A_{c} - s}\n$$\nDistributing $s$ in the numerator:\n$$\nv^{\\ast} = \\frac{s \\rho A_{c} - s^{2} + K_{D}^{2D} s A_{c}}{\\rho A_{c} - s}\n$$\nFactoring out common terms in the numerator gives the final closed-form expression:\n$$\nv^{\\ast} = \\frac{s(\\rho A_{c} + K_{D}^{2D} A_{c} - s)}{\\rho A_{c} - s}\n$$\nThis is the minimal valency $v^{\\ast}$ required to achieve an average of $s$ bonds at equilibrium, expressed as a function of the given parameters $s$, $\\rho$, $A_{c}$, and $K_{D}^{2D}$.", "answer": "$$\n\\boxed{\\frac{s(\\rho A_{c} + K_{D}^{2D} A_{c} - s)}{\\rho A_{c} - s}}\n$$", "id": "2847979"}, {"introduction": "Immune responses are not simple on-off switches but are finely tuned by a balance of competing signals. Many immune cells, including macrophages, co-express activating (ITAM-bearing) and inhibitory (ITIM-bearing) Fc receptors that bind the same immune complexes. This practice delves into the kinetics of this regulatory system, tasking you with modeling how receptor expression levels, binding affinities, and internalization rates collectively determine a \"balance point\"—the specific ligand concentration where opposing signals cancel out. [@problem_id:2847988]", "problem": "A macrophage co-expresses an activating fragment crystallizable gamma receptor (FcγR; a member of the fragment crystallizable receptor (FcR) family) that signals via an immunoreceptor tyrosine-based activation motif (ITAM) and an inhibitory fragment crystallizable gamma receptor that signals via an immunoreceptor tyrosine-based inhibitory motif (ITIM). Both receptors bind the same multivalent immunoglobulin G (IgG) immune complexes in the extracellular medium. The extracellular immune complex concentration, denoted by $L$, is constant in time, and ligand depletion is negligible.\n\nFor each receptor class $j \\in \\{\\mathrm{A}, \\mathrm{I}\\}$ (activating $\\mathrm{A}$, inhibitory $\\mathrm{I}$), let $R_{j}$ denote the total number of surface receptors per cell maintained at steady state by constitutive recycling, and consider the binding scheme $\\mathrm{R}_{j} + \\mathrm{L} \\rightleftharpoons \\mathrm{C}_{j}$ with second-order association rate constant $k_{\\mathrm{on},j}$ and first-order dissociation rate constant $k_{\\mathrm{off},j}$. Receptor–ligand complexes $\\mathrm{C}_{j}$ undergo endocytic removal with first-order rate constant $k_{\\mathrm{int},j}$. Assume that, on the timescale of interest, constitutive recycling maintains the surface receptor pool $R_{j}$ constant despite endocytosis, and that the quasi-steady-state of complex formation holds. The net signaling index is modeled as\n$\nS(L) \\equiv \\gamma_{\\mathrm{A}} \\, C_{\\mathrm{A}}(L) \\;-\\; \\gamma_{\\mathrm{I}} \\, C_{\\mathrm{I}}(L),\n$\nwhere $\\gamma_{\\mathrm{A}}$ and $\\gamma_{\\mathrm{I}}$ are dimensionless per-occupied-receptor signaling weights for the activating and inhibitory pathways, respectively, and $C_{j}(L)$ is the steady-state number of surface complexes for receptor class $j$.\n\nStarting only from the law of mass action and the definition of first-order removal for $\\mathrm{C}_{j}$, derive the steady-state expression for $C_{j}(L)$ in terms of $L$, $R_{j}$, $k_{\\mathrm{on},j}$, $k_{\\mathrm{off},j}$, and $k_{\\mathrm{int},j}$, and hence an analytic expression for the unique $L^{\\ast}  0$ such that $S(L^{\\ast}) = 0$.\n\nUse the following parameters, which are scientifically plausible for human Fcγ receptors engaging IgG immune complexes:\n- Activating receptor: $R_{\\mathrm{A}} = 4.0 \\times 10^{4}$, $k_{\\mathrm{on},\\mathrm{A}} = 1.0 \\times 10^{5} \\ \\mathrm{M}^{-1} \\, \\mathrm{s}^{-1}$, $k_{\\mathrm{off},\\mathrm{A}} = 5.0 \\times 10^{-3} \\ \\mathrm{s}^{-1}$, $k_{\\mathrm{int},\\mathrm{A}} = 2.0 \\times 10^{-3} \\ \\mathrm{s}^{-1}$, $\\gamma_{\\mathrm{A}} = 1.0$.\n- Inhibitory receptor: $R_{\\mathrm{I}} = 3.0 \\times 10^{4}$, $k_{\\mathrm{on},\\mathrm{I}} = 2.0 \\times 10^{5} \\ \\mathrm{M}^{-1} \\, \\mathrm{s}^{-1}$, $k_{\\mathrm{off},\\mathrm{I}} = 4.0 \\times 10^{-3} \\ \\mathrm{s}^{-1}$, $k_{\\mathrm{int},\\mathrm{I}} = 1.0 \\times 10^{-3} \\ \\mathrm{s}^{-1}$, $\\gamma_{\\mathrm{I}} = 1.2$.\n\nReport the value of $L^{\\ast}$ in nanomolar (nM). Round your final answer to four significant figures. Do not include units in your final boxed answer.", "solution": "The problem posed is valid, scientifically grounded, and well-posed. It requires the application of standard principles of chemical kinetics to a model of cell signaling. I will proceed with the derivation.\n\nFor each receptor class $j \\in \\{\\mathrm{A}, \\mathrm{I}\\}$, the number of receptor-ligand complexes on the cell surface, $C_j$, is governed by the law of mass action. The rate of change of $C_j$ is determined by three processes: association of free receptors with the ligand, dissociation of the complex, and endocytic removal of the complex.\n\nThe rate equation is:\n$$\n\\frac{dC_j}{dt} = k_{\\mathrm{on},j} L [R_j]_{\\text{free}} - k_{\\mathrm{off},j} C_j - k_{\\mathrm{int},j} C_j\n$$\nwhere $[R_j]_{\\text{free}}$ is the number of free receptors of class $j$. The total number of receptors of class $j$, $R_j$, is assumed to be constant and is the sum of free and bound receptors:\n$$\nR_j = [R_j]_{\\text{free}} + C_j\n$$\nThus, the number of free receptors is $[R_j]_{\\text{free}} = R_j - C_j$. Substituting this into the rate equation gives:\n$$\n\\frac{dC_j}{dt} = k_{\\mathrm{on},j} L (R_j - C_j) - (k_{\\mathrm{off},j} + k_{\\mathrm{int},j}) C_j\n$$\nThe problem specifies that the system is at a quasi-steady-state, meaning $\\frac{dC_j}{dt} = 0$. This yields an algebraic equation for the steady-state number of complexes, $C_j(L)$:\n$$\n0 = k_{\\mathrm{on},j} L (R_j - C_j(L)) - (k_{\\mathrm{off},j} + k_{\\mathrm{int},j}) C_j(L)\n$$\nWe solve for $C_j(L)$:\n$$\nk_{\\mathrm{on},j} L R_j - k_{\\mathrm{on},j} L C_j(L) = (k_{\\mathrm{off},j} + k_{\\mathrm{int},j}) C_j(L)\n$$\n$$\nk_{\\mathrm{on},j} L R_j = (k_{\\mathrm{on},j} L + k_{\\mathrm{off},j} + k_{\\mathrm{int},j}) C_j(L)\n$$\nThe steady-state expression for $C_j(L)$ is therefore:\n$$\nC_j(L) = \\frac{k_{\\mathrm{on},j} R_j L}{k_{\\mathrm{on},j} L + k_{\\mathrm{off},j} + k_{\\mathrm{int},j}}\n$$\nThis expression can be simplified by defining an effective dissociation constant, $K_{D,j}^{\\text{eff}}$, which incorporates both ligand dissociation and complex internalization:\n$$\nK_{D,j}^{\\text{eff}} \\equiv \\frac{k_{\\mathrm{off},j} + k_{\\mathrm{int},j}}{k_{\\mathrm{on},j}}\n$$\nWith this definition, the expression for $C_j(L)$ becomes a Langmuir-type isotherm:\n$$\nC_j(L) = \\frac{R_j L}{L + K_{D,j}^{\\text{eff}}}\n$$\nThis is the required steady-state expression for the number of surface complexes.\n\nNext, we must find the unique positive ligand concentration $L^{\\ast}  0$ for which the net signaling index $S(L^{\\ast})$ is zero. The signaling index is defined as:\n$$\nS(L) = \\gamma_{\\mathrm{A}} C_{\\mathrm{A}}(L) - \\gamma_{\\mathrm{I}} C_{\\mathrm{I}}(L)\n$$\nSetting $S(L^{\\ast}) = 0$:\n$$\n\\gamma_{\\mathrm{A}} C_{\\mathrm{A}}(L^{\\ast}) = \\gamma_{\\mathrm{I}} C_{\\mathrm{I}}(L^{\\ast})\n$$\nSubstituting the derived expression for $C_j(L)$:\n$$\n\\gamma_{\\mathrm{A}} \\frac{R_{\\mathrm{A}} L^{\\ast}}{L^{\\ast} + K_{D,\\mathrm{A}}^{\\text{eff}}} = \\gamma_{\\mathrm{I}} \\frac{R_{\\mathrm{I}} L^{\\ast}}{L^{\\ast} + K_{D,\\mathrm{I}}^{\\text{eff}}}\n$$\nSince we seek a solution for $L^{\\ast}  0$, we can divide both sides by $L^{\\ast}$:\n$$\n\\frac{\\gamma_{\\mathrm{A}} R_{\\mathrm{A}}}{L^{\\ast} + K_{D,\\mathrm{A}}^{\\text{eff}}} = \\frac{\\gamma_{\\mathrm{I}} R_{\\mathrm{I}}}{L^{\\ast} + K_{D,\\mathrm{I}}^{\\text{eff}}}\n$$\nWe solve this equation for $L^{\\ast}$:\n$$\n\\gamma_{\\mathrm{A}} R_{\\mathrm{A}} (L^{\\ast} + K_{D,\\mathrm{I}}^{\\text{eff}}) = \\gamma_{\\mathrm{I}} R_{\\mathrm{I}} (L^{\\ast} + K_{D,\\mathrm{A}}^{\\text{eff}})\n$$\n$$\n\\gamma_{\\mathrm{A}} R_{\\mathrm{A}} L^{\\ast} + \\gamma_{\\mathrm{A}} R_{\\mathrm{A}} K_{D,\\mathrm{I}}^{\\text{eff}} = \\gamma_{\\mathrm{I}} R_{\\mathrm{I}} L^{\\ast} + \\gamma_{\\mathrm{I}} R_{\\mathrm{I}} K_{D,\\mathrm{A}}^{\\text{eff}}\n$$\n$$\nL^{\\ast} (\\gamma_{\\mathrm{A}} R_{\\mathrm{A}} - \\gamma_{\\mathrm{I}} R_{\\mathrm{I}}) = \\gamma_{\\mathrm{I}} R_{\\mathrm{I}} K_{D,\\mathrm{A}}^{\\text{eff}} - \\gamma_{\\mathrm{A}} R_{\\mathrm{A}} K_{D,\\mathrm{I}}^{\\text{eff}}\n$$\nThe analytic expression for $L^{\\ast}$ is:\n$$\nL^{\\ast} = \\frac{\\gamma_{\\mathrm{I}} R_{\\mathrm{I}} K_{D,\\mathrm{A}}^{\\text{eff}} - \\gamma_{\\mathrm{A}} R_{\\mathrm{A}} K_{D,\\mathrm{I}}^{\\text{eff}}}{\\gamma_{\\mathrm{A}} R_{\\mathrm{A}} - \\gamma_{\\mathrm{I}} R_{\\mathrm{I}}}\n$$\nNow we must compute the numerical value of $L^{\\ast}$ using the provided parameters. First, we calculate the effective dissociation constants:\n$$\nK_{D,\\mathrm{A}}^{\\text{eff}} = \\frac{k_{\\mathrm{off},\\mathrm{A}} + k_{\\mathrm{int},\\mathrm{A}}}{k_{\\mathrm{on},\\mathrm{A}}} = \\frac{5.0 \\times 10^{-3} \\, \\mathrm{s}^{-1} + 2.0 \\times 10^{-3} \\, \\mathrm{s}^{-1}}{1.0 \\times 10^{5} \\, \\mathrm{M}^{-1} \\mathrm{s}^{-1}} = \\frac{7.0 \\times 10^{-3}}{1.0 \\times 10^{5}} \\, \\mathrm{M} = 7.0 \\times 10^{-8} \\, \\mathrm{M}\n$$\n$$\nK_{D,\\mathrm{I}}^{\\text{eff}} = \\frac{k_{\\mathrm{off},\\mathrm{I}} + k_{\\mathrm{int},\\mathrm{I}}}{k_{\\mathrm{on},\\mathrm{I}}} = \\frac{4.0 \\times 10^{-3} \\, \\mathrm{s}^{-1} + 1.0 \\times 10^{-3} \\, \\mathrm{s}^{-1}}{2.0 \\times 10^{5} \\, \\mathrm{M}^{-1} \\mathrm{s}^{-1}} = \\frac{5.0 \\times 10^{-3}}{2.0 \\times 10^{5}} \\, \\mathrm{M} = 2.5 \\times 10^{-8} \\, \\mathrm{M}\n$$\nNext, we compute the products of signaling weights and receptor numbers:\n$$\n\\gamma_{\\mathrm{A}} R_{\\mathrm{A}} = 1.0 \\times (4.0 \\times 10^{4}) = 4.0 \\times 10^{4}\n$$\n$$\n\\gamma_{\\mathrm{I}} R_{\\mathrm{I}} = 1.2 \\times (3.0 \\times 10^{4}) = 3.6 \\times 10^{4}\n$$\nNow, substitute these values into the expression for $L^{\\ast}$.\nThe numerator is:\n$$\n\\text{Numerator} = (3.6 \\times 10^{4}) \\times (7.0 \\times 10^{-8} \\, \\mathrm{M}) - (4.0 \\times 10^{4}) \\times (2.5 \\times 10^{-8} \\, \\mathrm{M})\n$$\n$$\n\\text{Numerator} = (25.2 \\times 10^{-4} - 10.0 \\times 10^{-4}) \\, \\mathrm{M} = 15.2 \\times 10^{-4} \\, \\mathrm{M} = 1.52 \\times 10^{-3} \\, \\mathrm{M}\n$$\nThe denominator is:\n$$\n\\text{Denominator} = 4.0 \\times 10^{4} - 3.6 \\times 10^{4} = 0.4 \\times 10^{4} = 4.0 \\times 10^{3}\n$$\nFinally, we calculate $L^{\\ast}$:\n$$\nL^{\\ast} = \\frac{1.52 \\times 10^{-3} \\, \\mathrm{M}}{4.0 \\times 10^{3}} = 0.38 \\times 10^{-6} \\, \\mathrm{M} = 3.8 \\times 10^{-7} \\, \\mathrm{M}\n$$\nThe problem requires the answer in nanomolar (nM). Since $1 \\, \\mathrm{M} = 10^9 \\, \\mathrm{nM}$:\n$$\nL^{\\ast} = 3.8 \\times 10^{-7} \\, \\mathrm{M} \\times \\frac{10^9 \\, \\mathrm{nM}}{1 \\, \\mathrm{M}} = 3.8 \\times 10^{2} \\, \\mathrm{nM} = 380 \\, \\mathrm{nM}\n$$\nThe final answer must be rounded to four significant figures. Thus, $380$ is written as $380.0$.", "answer": "$$\\boxed{380.0}$$", "id": "2847988"}, {"introduction": "Having modeled the balance of receptor engagement at the membrane, we now follow these signals into the cell to understand how they are integrated into a coherent biochemical response. This advanced exercise models the competition between activating PI3-Kinase and inhibitory SHIP phosphatase as they control the level of the critical second messenger phosphatidylinositol (3,4,5)-trisphosphate ($\\mathrm{PIP}_{3}$). By connecting receptor occupancy to Michaelis–Menten enzyme kinetics, you will calculate the precise steady-state outcome of this signaling tug-of-war, providing a powerful example of quantitative systems biology. [@problem_id:2848000]", "problem": "A macrophage expresses both the activating Fc gamma receptor IIA (FcγRIIA) and the inhibitory Fc gamma receptor IIB (FcγRIIB). Upon contact with multivalent immunoglobulin G immune complexes, receptors co-aggregate into microclusters. Assume the following mechanistic bases: (i) receptor–ligand binding at the plasma membrane obeys the law of mass action, characterized at steady state by the equilibrium dissociation constant $K_{D} = k_{\\mathrm{off}}/k_{\\mathrm{on}}$ and fractional occupancy $\\theta = L/(K_{D} + L)$ for a local ligand concentration $L$; (ii) co-aggregation recruits enzymes that modulate a shared second messenger at the membrane, phosphatidylinositol $(3,4,5)$-trisphosphate ($\\mathrm{PIP}_{3}$), whose normalized fraction $y \\in [0,1]$ evolves by standard Michaelis–Menten production from phosphatidylinositol $(4,5)$-bisphosphate ($\\mathrm{PIP}_{2}$) and degradation back to $\\mathrm{PIP}_{2}$; and (iii) production is catalyzed by Phosphatidylinositol $3$-kinase (PI3K) recruited by occupied FcγRIIA, while degradation is catalyzed by Src homology $2$ domain-containing inositol $5$-phosphatase (SHIP) with a baseline activity plus additional recruitment via co-aggregated FcγRIIB.\n\nYou are given:\n- Activating receptor (FcγRIIA): $k_{\\mathrm{on},A} = 1.0 \\times 10^{6} \\ \\mathrm{M}^{-1}\\mathrm{s}^{-1}$, $k_{\\mathrm{off},A} = 1.0 \\times 10^{-1} \\ \\mathrm{s}^{-1}$, total receptors $N_{A}^{\\mathrm{tot}} = 3.0 \\times 10^{4}$.\n- Inhibitory receptor (FcγRIIB): $k_{\\mathrm{on},I} = 0.7 \\times 10^{6} \\ \\mathrm{M}^{-1}\\mathrm{s}^{-1}$, $k_{\\mathrm{off},I} = 1.4 \\times 10^{-1} \\ \\mathrm{s}^{-1}$, total receptors $N_{I}^{\\mathrm{tot}} = 2.0 \\times 10^{4}$.\n- Local immune complex concentration: $L = 5.0 \\times 10^{-8} \\ \\mathrm{M}$.\n- Michaelis–Menten parameters for $\\mathrm{PIP}_{3}$ cycling: production maximum rate $V_{k} = v_{k}^{(0)} N_{A}^{\\mathrm{occ}}$ with $v_{k}^{(0)} = 2.0 \\times 10^{-6} \\ \\mathrm{s}^{-1}$ per occupied FcγRIIA; degradation maximum rate $V_{p} = v_{p}^{\\mathrm{base}} + v_{p}^{(I)} N_{I}^{\\mathrm{coagg}}$ with $v_{p}^{\\mathrm{base}} = 1.8 \\times 10^{-2} \\ \\mathrm{s}^{-1}$ and $v_{p}^{(I)} = 3.0 \\times 10^{-9} \\ \\mathrm{s}^{-1}$ per co-aggregated FcγRIIB.\n- Michaelis constants: $K_{k} = 0.10$ and $K_{p} = 0.10$ (dimensionless fractions of the $\\mathrm{PIP}_{2}/\\mathrm{PIP}_{3}$ pool).\n- Co-aggregation assumption: in the regime of multivalent immune complexes, the probability that an occupied FcγRIIA resides in a co-aggregated microcluster with FcγRIIB equals the FcγRIIB fractional occupancy, so that $N_{I}^{\\mathrm{coagg}} = p \\, N_{A}^{\\mathrm{occ}}$ with $p = \\theta_{I}$.\n\nTasks:\n1. Using $K_{D} = k_{\\mathrm{off}}/k_{\\mathrm{on}}$ and $\\theta = L/(K_{D} + L)$, compute the steady-state occupancies $\\theta_{A}$ and $\\theta_{I}$ and the numbers $N_{A}^{\\mathrm{occ}}$ and $N_{I}^{\\mathrm{coagg}}$.\n2. Using the Michaelis–Menten forms for production $v_{k}(y) = V_{k} \\, \\dfrac{1 - y}{K_{k} + (1 - y)}$ and degradation $v_{p}(y) = V_{p} \\, \\dfrac{y}{K_{p} + y}$, impose steady state by equating production and degradation and solve for the steady-state $\\mathrm{PIP}_{3}$ fraction $y^{\\ast}$.\n\nReport $y^{\\ast}$ as a decimal fraction, rounded to four significant figures. Do not include any units in your final answer.", "solution": "The problem is subjected to validation and is found to be scientifically grounded, well-posed, and internally consistent. It presents a quantitative model of a cellular signaling pathway, which is a standard task in systems biology. All necessary parameters and governing equations are provided, allowing for a unique solution to be determined through a systematic, multi-step calculation. The problem is therefore deemed valid. The solution proceeds as follows.\n\nThe problem is solved in two main parts. First, the steady-state occupancy of the activating (FcγRIIA) and inhibitory (FcγRIIB) receptors is calculated. Second, these occupancies are used to parameterize the Michaelis–Menten kinetics of phosphatidylinositol $(3,4,5)$-trisphosphate ($\\mathrm{PIP}_{3}$) production and degradation, from which the steady-state fraction of $\\mathrm{PIP}_{3}$, denoted $y^{\\ast}$, is determined.\n\nPart 1: Receptor Occupancy Calculation\n\nThe equilibrium dissociation constant, $K_D$, for each receptor type is calculated from the given on- and off-rates, $K_D = k_{\\mathrm{off}}/k_{\\mathrm{on}}$.\n\nFor the activating receptor, FcγRIIA (subscript $A$):\n$k_{\\mathrm{on},A} = 1.0 \\times 10^{6} \\ \\mathrm{M}^{-1}\\mathrm{s}^{-1}$\n$k_{\\mathrm{off},A} = 1.0 \\times 10^{-1} \\ \\mathrm{s}^{-1}$\n$$K_{D,A} = \\frac{k_{\\mathrm{off},A}}{k_{\\mathrm{on},A}} = \\frac{1.0 \\times 10^{-1} \\ \\mathrm{s}^{-1}}{1.0 \\times 10^{6} \\ \\mathrm{M}^{-1}\\mathrm{s}^{-1}} = 1.0 \\times 10^{-7} \\ \\mathrm{M}$$\n\nFor the inhibitory receptor, FcγRIIB (subscript $I$):\n$k_{\\mathrm{on},I} = 0.7 \\times 10^{6} \\ \\mathrm{M}^{-1}\\mathrm{s}^{-1}$\n$k_{\\mathrm{off},I} = 1.4 \\times 10^{-1} \\ \\mathrm{s}^{-1}$\n$$K_{D,I} = \\frac{k_{\\mathrm{off},I}}{k_{\\mathrm{on},I}} = \\frac{1.4 \\times 10^{-1} \\ \\mathrm{s}^{-1}}{0.7 \\times 10^{6} \\ \\mathrm{M}^{-1}\\mathrm{s}^{-1}} = 2.0 \\times 10^{-7} \\ \\mathrm{M}$$\n\nThe fractional occupancy, $\\theta$, for each receptor is then calculated using the provided ligand concentration $L = 5.0 \\times 10^{-8} \\ \\mathrm{M}$ and the mass-action binding formula $\\theta = L/(K_{D} + L)$.\n\nFor FcγRIIA:\n$$\\theta_{A} = \\frac{L}{K_{D,A} + L} = \\frac{5.0 \\times 10^{-8} \\ \\mathrm{M}}{1.0 \\times 10^{-7} \\ \\mathrm{M} + 5.0 \\times 10^{-8} \\ \\mathrm{M}} = \\frac{5.0 \\times 10^{-8}}{1.5 \\times 10^{-7}} = \\frac{1}{3}$$\n\nFor FcγRIIB:\n$$\\theta_{I} = \\frac{L}{K_{D,I} + L} = \\frac{5.0 \\times 10^{-8} \\ \\mathrm{M}}{2.0 \\times 10^{-7} \\ \\mathrm{M} + 5.0 \\times 10^{-8} \\ \\mathrm{M}} = \\frac{5.0 \\times 10^{-8}}{2.5 \\times 10^{-7}} = \\frac{1}{5} = 0.2$$\n\nWith the fractional occupancies, we calculate the number of occupied activating receptors, $N_{A}^{\\mathrm{occ}}$, and the number of co-aggregated inhibitory receptors, $N_{I}^{\\mathrm{coagg}}$.\nGiven the total number of activating receptors $N_{A}^{\\mathrm{tot}} = 3.0 \\times 10^{4}$:\n$$N_{A}^{\\mathrm{occ}} = \\theta_{A} N_{A}^{\\mathrm{tot}} = \\frac{1}{3} \\times (3.0 \\times 10^{4}) = 1.0 \\times 10^{4}$$\n\nThe number of co-aggregated FcγRIIB is given by the assumption $N_{I}^{\\mathrm{coagg}} = p \\, N_{A}^{\\mathrm{occ}}$ with $p = \\theta_{I}$:\n$$N_{I}^{\\mathrm{coagg}} = \\theta_{I} N_{A}^{\\mathrm{occ}} = 0.2 \\times (1.0 \\times 10^{4}) = 2.0 \\times 10^{3}$$\n\nPart 2: Steady-State $\\mathrm{PIP}_{3}$ Fraction Calculation\n\nThe maximum rates for $\\mathrm{PIP}_3$ production ($V_k$) and degradation ($V_p$) depend on the number of active receptors calculated in Part 1.\n\nThe maximum production rate, $V_k$, is catalyzed by PI3K recruited by occupied FcγRIIA:\n$$V_{k} = v_{k}^{(0)} N_{A}^{\\mathrm{occ}} = (2.0 \\times 10^{-6} \\ \\mathrm{s}^{-1}) \\times (1.0 \\times 10^{4}) = 2.0 \\times 10^{-2} \\ \\mathrm{s}^{-1}$$\n\nThe maximum degradation rate, $V_p$, has a basal component and a component recruited by co-aggregated FcγRIIB:\n$$V_{p} = v_{p}^{\\mathrm{base}} + v_{p}^{(I)} N_{I}^{\\mathrm{coagg}} = (1.8 \\times 10^{-2} \\ \\mathrm{s}^{-1}) + (3.0 \\times 10^{-9} \\ \\mathrm{s}^{-1}) \\times (2.0 \\times 10^{3})$$\n$$V_{p} = 1.8 \\times 10^{-2} \\ \\mathrm{s}^{-1} + 6.0 \\times 10^{-6} \\ \\mathrm{s}^{-1} = 0.018006 \\ \\mathrm{s}^{-1}$$\n\nAt steady state, the rate of $\\mathrm{PIP}_{3}$ production, $v_k(y)$, equals the rate of its degradation, $v_p(y)$. Using the provided Michaelis–Menten expressions with $y = y^{\\ast}$:\n$$v_{k}(y^{\\ast}) = V_{k} \\frac{1 - y^{\\ast}}{K_{k} + (1 - y^{\\ast})} = V_{p} \\frac{y^{\\ast}}{K_{p} + y^{\\ast}} = v_{p}(y^{\\ast})$$\nWe are given $K_{k} = 0.10$ and $K_{p} = 0.10$. Substituting the values for $V_k$, $V_p$, $K_k$, and $K_p$:\n$$(2.0 \\times 10^{-2}) \\frac{1 - y^{\\ast}}{0.10 + 1 - y^{\\ast}} = (0.018006) \\frac{y^{\\ast}}{0.10 + y^{\\ast}}$$\n$$(2.0 \\times 10^{-2}) \\frac{1 - y^{\\ast}}{1.1 - y^{\\ast}} = (0.018006) \\frac{y^{\\ast}}{0.10 + y^{\\ast}}$$\nTo solve for $y^{\\ast}$, we rearrange the equation:\n$$\\frac{1 - y^{\\ast}}{1.1 - y^{\\ast}} = \\frac{0.018006}{2.0 \\times 10^{-2}} \\frac{y^{\\ast}}{0.10 + y^{\\ast}} = 0.9003 \\frac{y^{\\ast}}{0.10 + y^{\\ast}}$$\nCross-multiplication yields:\n$$(1 - y^{\\ast})(0.10 + y^{\\ast}) = 0.9003 y^{\\ast} (1.1 - y^{\\ast})$$\nExpanding both sides of the equation:\n$$0.10 + y^{\\ast} - 0.10 y^{\\ast} - (y^{\\ast})^2 = 0.9003 \\times 1.1 y^{\\ast} - 0.9003 (y^{\\ast})^2$$\n$$0.10 + 0.9 y^{\\ast} - (y^{\\ast})^2 = 0.99033 y^{\\ast} - 0.9003 (y^{\\ast})^2$$\nThis is rearranged into a standard quadratic form, $ay^2 + by + c = 0$:\n$$(1 - 0.9003)(y^{\\ast})^2 + (0.99033 - 0.9)y^{\\ast} - 0.10 = 0$$\n$$0.0997 (y^{\\ast})^2 + 0.09033 y^{\\ast} - 0.10 = 0$$\nWe solve for $y^{\\ast}$ using the quadratic formula, $y^{\\ast} = \\frac{-b \\pm \\sqrt{b^2 - 4ac}}{2a}$:\n$$y^{\\ast} = \\frac{-0.09033 \\pm \\sqrt{(0.09033)^2 - 4(0.0997)(-0.10)}}{2(0.0997)}$$\n$$y^{\\ast} = \\frac{-0.09033 \\pm \\sqrt{0.0081594889 + 0.03988}}{0.1994}$$\n$$y^{\\ast} = \\frac{-0.09033 \\pm \\sqrt{0.0480394889}}{0.1994}$$\n$$y^{\\ast} = \\frac{-0.09033 \\pm 0.219179125}{0.1994}$$\nThe two possible mathematical solutions are:\n$$y^{\\ast}_{1} = \\frac{-0.09033 + 0.219179125}{0.1994} = \\frac{0.128849125}{0.1994} \\approx 0.646184$$\n$$y^{\\ast}_{2} = \\frac{-0.09033 - 0.219179125}{0.1994} = \\frac{-0.309509125}{0.1994} \\approx -1.55219$$\nSince $y^{\\ast}$ represents a physical fraction of a chemical pool, it must be within the interval $[0,1]$. Thus, the only physically valid solution is $y^{\\ast}_{1}$.\nRounding the result to four significant figures as required:\n$$y^{\\ast} \\approx 0.6462$$", "answer": "$$\\boxed{0.6462}$$", "id": "2848000"}]}